Sawlani, Sarena

Sawlani, Sarena was paid $187K by Medicaid between Apr 2018 and Nov 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 74% of everything it billed.

33Billing provider infoSAWLANI, SARENA
CHICAGO, IL 60631

33aNPI1386807816assigned 07/03/2008

33bProvider typeAllergy & Immunology Physician

28Total paid$187K

24GClaims3,473

24DCodes billed7

24AFirst – last monthApr 2018 – Nov 2024

Compared with peers

Next to other Allergy & Immunology Physician providers in Illinois

Rank by total paid#13 of 58

Median peer was paid$27K

This provider vs. median6.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	67	$3K
2019	341	$16K
2020	539	$26K
2021	591	$27K
2022	531	$31K
2023	722	$40K
2024incomplete	682	$44K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	74%	2,292	2,091	$138K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	13%	721	638	$25K
99244	Office or other outpatient consultation, moderate to high complexity	10%	163	150	$19K
99243		1.2%	27	27	$2K
96160		<1%	101	93	$1K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	25	25	$992.34
99072		0%	144	114	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.